End-stage Renal Disease
📧 Sign up to get email alerts when something new happens for End-stage Renal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus. [Phase 1, Phase 2]
A pharmacokinetic comparability study of Triferic AVNU IV administered by continuous infusion versus IV bolus in End Stage Renal Disease has…
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease [Phase 3]
Phase 3 trial update assessing efficacy and safety of lanthanum carbonate and sevelamer hydrochloride in patients on haemodialysis for end-s…
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease [Phase 4]
Phase 4 trial update reporting on efficacy and safety of Fosrenol for elevated serum phosphate in adults with end-stage renal disease.
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis [Phase 3]
Phase 3 trial update evaluating efficacy and tolerability of lanthanum carbonate in end stage renal disease patients on dialysis.
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients [Phase 2]
Phase 2 trial assessing safety and efficacy of etanercept in hemodialysis patients with end-stage renal disease; study terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Evaluate the Efficacy and Safety of HIF-PHI for the Treatment of Anemia and Risks of Cardiovascular and Cerebrovascular Events in ESRD Newly Initiated Dialysis Patients [Phase 4]
Phase 4 trial evaluating efficacy and safety of a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) for anemia in incident dia…
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Pilot Study of Nutrition in Maintenance Hemodialysis Patients [NA]
Pilot study on nutrition in maintenance hemodialysis patients has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD [Phase 4]
Phase 4 trial evaluating safety and cardiovascular efficacy of hydralazine combined with isosorbide dinitrate in patients with dialysis-depe…
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC) [Phase 3]
A Phase 3 clinical trial update on ferric pyrophosphate citrate (FPC) for hemoglobin maintenance in pediatric patients with end-stage renal …
-
CLINICAL_TRIALS trial_result · 2021-04-12Clinical Trial Update: Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan [Phase 3]
Phase 3 efficacy and safety study evaluating MT-6548 in adults with anemia associated with chronic kidney disease requiring hemodialysis in …
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome [Phase 2]
Phase 2 trial assessing how an antibiotic impacts production of uremic toxins by the gut microbiome in end-stage renal disease.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD) [Phase 2]
Phase 2 trial completed evaluating SNF472 for progression of vascular calcification in end-stage renal disease patients on hemodialysis; res…
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal Dialysis [Phase 4]
Phase 4 trial update examining sympathetic activity in patients with end-stage renal disease on peritoneal dialysis has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-10Clinical Trial Update: Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis [Phase 3]
A Phase 3 clinical trial evaluating ferric citrate for treating hyperphosphatemia in patients with chronic kidney disease on hemodialysis ha…
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens [NA]
Clinical trial assessing two immunosuppressive regimens in renal transplant recipients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Effect of Amlodipine Versus Bisoprolol on Hypertensive Patients With End-stage Renal Disease on Maintenance Hemodialysis. [Phase 4]
A Phase 4 trial comparing amlodipine to bisoprolol in hypertensive patients with end-stage renal disease on maintenance hemodialysis has com…
-
CLINICAL_TRIALS research · 2021-02-15Clinical Trial Update: Monitoring in Dialysis -- a Prospective, Multi-center, Single-arm, Non-randomized, Observational Study in Patients Who Are Undergoing Hemodialysis. [NA]
An observational, non-randomized study in hemodialysis patients assessing monitoring in dialysis; completed with results posted.
-
FDA approval · 2021-02-11FDA Approved: PARSABIV — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for PARSABIV (etelcalcetide) from Amgen, Inc., updating the labeling as part of the supplemental sub…
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC [NA]
A completed clinical trial comparing VectorFlow Tunneled Dialysis Catheter (TDC) with Palindrome TDC in patients requiring hemodialysis for …
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Performance Evaluation of the AMIA APD Solution Generation System in Patients End Stage Renal Disease (ESRD) [NA]
Terminated clinical trial evaluating the AMIA APD Solution Generation System in patients with end-stage renal disease; results were posted o…
-
FDA approval · 2021-01-26FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA approves a supplemental application for DELFLEX, a dialysis solution containing dextrose monohydrate and electrolytes, manufactured by F…
-
FDA approval · 2021-01-26FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
The FDA approved a supplemental application for DELFLEX, a dialysis solution from Fresenius Medical Care North America, to update its formul…
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis [Phase 1, Phase 2]
A clinical trial update reports the safety assessment of single doses of BMS-986177 in patients with end-stage renal disease on hemodialysis…
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation [Phase 4]
A Phase 4 trial evaluating anticoagulation therapy in hemodialysis patients with atrial fibrillation has completed with results posted in 20…
-
FDA approval · 2020-12-28FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Exelan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Sevelamer carbonate submitted by Exelan Pharmaceuticals Inc.